Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-02-06
2007-02-06
Sullivan, Daniel M. (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S326000
Reexamination Certificate
active
10848637
ABSTRACT:
The present invention provides Orphanin FQ receptor nucleic acids and polypeptides and uses thereof. In particular, the present invention provides nucleic acid sequences of differentially expressed splice variants of the Orphanin FQ receptor. The present invention also provides methods of using the Orphanin FQ receptor nucleic acid sequences and ligands for the identification of pharmaceutical agents, the generation of animal models of Orphanin FQ receptor-mediated disease states, and for formulating biological activities. The present invention further provides improved methods of screening potential therapeutics useful in the treatment of a variety of disease states mediated by Orphanin FQ signaling, as well as therapeutics identified using the screening methods.
REFERENCES:
patent: 4657760 (1987-04-01), Kung et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5206344 (1993-04-01), Katre et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5614396 (1997-03-01), Bradley et al.
patent: 5674713 (1997-10-01), McElroy et al.
patent: 5733731 (1998-03-01), Schatz et al.
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5821219 (1998-10-01), Grandy et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5837809 (1998-11-01), Grandy et al.
patent: 5929035 (1999-07-01), Owyang
patent: 5976796 (1999-11-01), Szalay et al.
patent: 5976807 (1999-11-01), Horlick et al.
patent: 6074859 (2000-06-01), Hirokawa et al.
patent: 6080912 (2000-06-01), Bremel et al.
patent: WO 84/03564 (1984-09-01), None
patent: WO 90/08832 (1990-08-01), None
patent: WO 93/03367 (1993-02-01), None
Reinsheid et al. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem. Jun. 14, 1996;271(24):14163-8.
Brownstein, Proc. Natl. Acad. Sci. USA 90:5391 [1993].
DiChara and North, Trends in Pharmacol. Sci. 13:185 [1992].
Wang et al., FEBS Lett. 348:75 [1994].
Bunzow et al., FEBS Lett. 347:284 [1994].
Darland et al., Trends Neurosci. 21:215 [1998].
Mollereau et al., FEBS Lett. 341:33 [1994].
Fukuda et al., FEBS Lett. 343:42 [1994].
Chen et al., FEBS Lett. 347:279 [1994].
Bunzow et al., FEBS Lett. 347:284 [1994].
Wick et al., Brain Res. Mol. Brain Res. 27:37 [1994].
Lachowicz et al., J. Neurochem. 64:34 [1995].
Nishi et al., Biochem. Biophys. Res. Commun. 205:1353 [1994].
Pan et al., Regul. Pept. 51:217 [1994].
Pan et al., Mol. Pharmacol. 47:1180 [1995].
Pan et al., Gene 171:255 [1996].
Reinscheid et al., Science 270:792 [1995].
Meunier et al., Nature 377:532 [1995].
Zhang et al., Brain Res. 772:102 [1997].
Yazdani et al., Gastroenterology 116:108 [1999].
Osinski et al., Eur. J. Pharmacol. 365:281 [1999].
Rossi et al., J. Pharmacol. Exp. Ther. 282:858 [1997].
Rossi et al., Brain Res. 792:327 [1998].
Noda et al., J. Biol. Chem. 273:18047 [1998].
Pan et al., FEBS Lett. 395:207 [1996].
Mathis et al., Biochem. Biophys. Res. Commun. 230:462 [1997].
Yamamoto and Nozaki-Taguchi, Anesthesiology 87:1145 [1997].
Blandizzi et al., Biochem. Biophys. Res. Commun. 202:947 [1994].
Mount, Nucleic Acids Res. 10:459 [1982].
Muraoka et al., Am. J. Physiol. 271:G1101 [1996].
Song et al., Proc. Natl. Acad. Sci. U S A. 90:9085 [1993].
Calo et al., Br. J. Pharmacol 129:1261 [2000].
Jenck et al. PNAS 97:4938 [2000].
Koster et al., PNAS 96:10444.
Allen et al., J. Neurosci., 19:2152 [1999].
Meng et al., J. Biol. Chem.,275:21939 [2000].
Takahashi et al., Gastroenterology 119:1054 [2000].
Takahashi et al., Gastroenterology 119:71 [2000] (abstract only).
Hashimoto et al., Neurosci. Lett. 278:109 [2000] (abstract only).
Hom et al., Synapse 34:187 [1999] (abstract only).
Goda and Mutneia, Curr. Biol., 8:R889 [1998] (abstract only).
Guerrini et al., J. Med. Chem., 43:2805 [2000] (abstract only).
Chiou, J. Biomed Sci. 7:232 [2000] (abstract only).
Berger et al., J. Pharmacol. Exp. Ther. 294:428 [2000] (abstract only).
Medlen & Carroll LLP
Regents of the University of Michigan
Sullivan Daniel M.
LandOfFree
Orphanin FQ receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orphanin FQ receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orphanin FQ receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872784